Despite sustained reductions in smoking prevalence and improvements in ambient air quality, lung cancer incidence in China continues to rise, suggesting that important risk factors remain insufficiently recognised. Asbestos is a well-established carcinogen, yet its contribution to China’s lung cancer burden has received limited attention, particularly given the continued use of chrysotile and widespread legacy asbestos-containing materials. This review highlights how non-specific clinical presentation, incomplete exposure documentation, and limitations in surveillance systems contribute to systematic underestimation of asbestos-related lung cancer. Diverse exposure scenarios, including occupational, para-occupational, and environmental pathways, further complicate etiologic attribution beyond traditionally defined asbestos workers. A comprehensive asbestos ban represents an important long-term strategy to reduce the future burden of asbestos-related disease in China.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: